Product Name:1-[2-(ethylcarbamoyl)-1,2,3,4-tetrahydroisoquinolin-5-yl]-5-methyl-1H-1,2,3-triazole-4-carboxylic acid

IUPAC Name:1-[2-(ethylcarbamoyl)-1,2,3,4-tetrahydroisoquinolin-5-yl]-5-methyl-1H-1,2,3-triazole-4-carboxylic acid

CAS:1315367-22-6
Molecular Formula:C16H19N5O3
Purity:95%+
Catalog Number:CM476675
Molecular Weight:329.36

Packing Unit Available Stock Price($) Quantity
CM476675-250mg 3-4 Weeks ƴǸƴ
CM476675-500mg 4-5 Weeks ƚħŮ
CM476675-1g 4-5 Weeks Ůijij

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1315367-22-6
Molecular Formula:C16H19N5O3
Melting Point:-
Smiles Code:CCNC(=O)N1CCC2=C(C1)C=CC=C2N1N=NC(C(O)=O)=C1C
Density:
Catalog Number:CM476675
Molecular Weight:329.36
Boiling Point:
MDL No:MFCD19381855
Storage:

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.
Tetrahydroisoquinolines
Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.

Related Products